FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899452252> ?p ?o ?g. }

• W2899452252 endingPage "4381" @default.
• W2899452252 startingPage "4374" @default.
• W2899452252 abstract "Purpose: To investigate whether PD-L1 mediated adaptive resistance could occur in treatment with Anchored-GM-CSF vaccine and whether PD-1 blockade combined with Anchored-GM-CSF vaccine could induce a greater anti-tumor immune response than either immunotherapy alone. Materials and Methods: After establishing long-established subcutaneous metastasis bladder cancer models, mice were treated with Anchored-GM-CSF vaccine and/or anti-PD-1 antibody. T-lymphocyte-cytotoxicity, flow cytometric analysis, immunohistochemical, immunofluorescence staining, CD8+ -T cell apoptosis and enzyme-linked immunosorbent assays were performed to evaluate the efficacy of combination therapy with anchored-GM-CSF vaccine and PD-1 blockade and to explore the related mechanism. Results: Anchored-GM-CSF vaccine could significantly increase the number of mature DCs and up-regulate PD-L1 expression dependent on IFN-γ released from CD8+ T cells. Anchored-GM-CSF vaccine combined with anti-PD-1 antibody could effectively inhibit tumor growth and even cause regression of the established tumor. More CD4+ and CD8+ T cells appeared at tumor sites and in peripheral blood in the combination therapy group than in the control groups. Splenocytes from mice of the combination therapy group exhibited the most potent cytotoxicity to MB49 cells. Apoptotic assays showed that PD-1 blockade could significantly reduce CD8+ T cells apoptosis. Conclusions: Anchored-GM-CSF vaccines and anti-PD-1 antibodies have synergistic effects in metastatic bladder cancer treatment. PD-1 blockade can overcome immune resistance in treatment with the Anchored-GM-CSF vaccine, while Anchored-GM-CSF vaccine can enhance the efficacy of PD-1 blockade therapy." @default.
• W2899452252 created "2018-11-09" @default.
• W2899452252 creator A5004143556 @default.
• W2899452252 creator A5019102566 @default.
• W2899452252 creator A5028558643 @default.
• W2899452252 creator A5040924420 @default.
• W2899452252 creator A5085747175 @default.
• W2899452252 creator A5086155499 @default.
• W2899452252 creator A5088772562 @default.
• W2899452252 creator A5088935892 @default.
• W2899452252 date "2018-01-01" @default.
• W2899452252 modified "2023-10-17" @default.
• W2899452252 title "PD-1 Blockade Overcomes Adaptive Immune Resistance in Treatment with Anchored-GM-CSF Bladder Cancer Cells Vaccine" @default.
• W2899452252 cites W1893566975 @default.
• W2899452252 cites W1971208896 @default.
• W2899452252 cites W2004286448 @default.
• W2899452252 cites W2016789384 @default.
• W2899452252 cites W2016983859 @default.
• W2899452252 cites W2030242066 @default.
• W2899452252 cites W2051830227 @default.
• W2899452252 cites W2057893793 @default.
• W2899452252 cites W2066671159 @default.
• W2899452252 cites W2086526310 @default.
• W2899452252 cites W2097855813 @default.
• W2899452252 cites W2102575291 @default.
• W2899452252 cites W2108052503 @default.
• W2899452252 cites W2108712362 @default.
• W2899452252 cites W2108758562 @default.
• W2899452252 cites W2111217091 @default.
• W2899452252 cites W2135885240 @default.
• W2899452252 cites W2136731993 @default.
• W2899452252 cites W2139766217 @default.
• W2899452252 cites W2289712604 @default.
• W2899452252 cites W2328010541 @default.
• W2899452252 cites W2546607321 @default.
• W2899452252 cites W2560367415 @default.
• W2899452252 cites W2584071843 @default.
• W2899452252 doi "https://doi.org/10.7150/jca.25423" @default.
• W2899452252 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6277664" @default.
• W2899452252 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30519342" @default.
• W2899452252 hasPublicationYear "2018" @default.
• W2899452252 type Work @default.
• W2899452252 sameAs 2899452252 @default.
• W2899452252 citedByCount "4" @default.
• W2899452252 countsByYear W28994522522019 @default.
• W2899452252 countsByYear W28994522522020 @default.
• W2899452252 countsByYear W28994522522021 @default.
• W2899452252 crossrefType "journal-article" @default.
• W2899452252 hasAuthorship W2899452252A5004143556 @default.
• W2899452252 hasAuthorship W2899452252A5019102566 @default.
• W2899452252 hasAuthorship W2899452252A5028558643 @default.
• W2899452252 hasAuthorship W2899452252A5040924420 @default.
• W2899452252 hasAuthorship W2899452252A5085747175 @default.
• W2899452252 hasAuthorship W2899452252A5086155499 @default.
• W2899452252 hasAuthorship W2899452252A5088772562 @default.
• W2899452252 hasAuthorship W2899452252A5088935892 @default.
• W2899452252 hasBestOaLocation W28994522521 @default.
• W2899452252 hasConcept C121608353 @default.
• W2899452252 hasConcept C126322002 @default.
• W2899452252 hasConcept C154317977 @default.
• W2899452252 hasConcept C159654299 @default.
• W2899452252 hasConcept C167672396 @default.
• W2899452252 hasConcept C170493617 @default.
• W2899452252 hasConcept C190283241 @default.
• W2899452252 hasConcept C202751555 @default.
• W2899452252 hasConcept C203014093 @default.
• W2899452252 hasConcept C2776090121 @default.
• W2899452252 hasConcept C2777701055 @default.
• W2899452252 hasConcept C2778378633 @default.
• W2899452252 hasConcept C2778468042 @default.
• W2899452252 hasConcept C2780352672 @default.
• W2899452252 hasConcept C502942594 @default.
• W2899452252 hasConcept C55493867 @default.
• W2899452252 hasConcept C71924100 @default.
• W2899452252 hasConcept C86803240 @default.
• W2899452252 hasConcept C8891405 @default.
• W2899452252 hasConceptScore W2899452252C121608353 @default.
• W2899452252 hasConceptScore W2899452252C126322002 @default.
• W2899452252 hasConceptScore W2899452252C154317977 @default.
• W2899452252 hasConceptScore W2899452252C159654299 @default.
• W2899452252 hasConceptScore W2899452252C167672396 @default.
• W2899452252 hasConceptScore W2899452252C170493617 @default.
• W2899452252 hasConceptScore W2899452252C190283241 @default.
• W2899452252 hasConceptScore W2899452252C202751555 @default.
• W2899452252 hasConceptScore W2899452252C203014093 @default.
• W2899452252 hasConceptScore W2899452252C2776090121 @default.
• W2899452252 hasConceptScore W2899452252C2777701055 @default.
• W2899452252 hasConceptScore W2899452252C2778378633 @default.
• W2899452252 hasConceptScore W2899452252C2778468042 @default.
• W2899452252 hasConceptScore W2899452252C2780352672 @default.
• W2899452252 hasConceptScore W2899452252C502942594 @default.
• W2899452252 hasConceptScore W2899452252C55493867 @default.
• W2899452252 hasConceptScore W2899452252C71924100 @default.
• W2899452252 hasConceptScore W2899452252C86803240 @default.
• W2899452252 hasConceptScore W2899452252C8891405 @default.
• W2899452252 hasIssue "23" @default.
• W2899452252 hasLocation W28994522521 @default.
• W2899452252 hasLocation W28994522522 @default.

• next